Towards molecular diagnosis and targeted therapy of lymphoid malignancies

被引：22
|
作者：
Wiestner, A
Staudt, LM
机构：
[1] NCI, Metab Branch, CCR, NIH, Bethesda, MD 20892 USA
[2] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
来源：
SEMINARS IN HEMATOLOGY | 2003年 / 40卷 / 04期
关键词：
D O I：
10.1016/S0037-1963(03)00194-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：296 / 307
页数：12
相关论文
共 50 条
  • [31] Diagnostic and prognostic molecular pathology of lymphoid malignancies
    Fend, Falko
    van den Brand, Michiel
    Groenen, Patricia J. T. A.
    Quintanilla-Martinez, Leticia
    Bagg, Adam
    VIRCHOWS ARCHIV, 2024, 484 (02) : 195 - 214
  • [32] MOLECULAR GENETIC-ANALYSIS OF LYMPHOID MALIGNANCIES
    SHIRAKAWA, S
    ACTA HAEMATOLOGICA JAPONICA, 1987, 50 (08): : 1475 - 1490
  • [33] CHANGING UTILIZATION OF RADIATION THERAPY IN LYMPHOID MALIGNANCIES
    Pickles, T.
    Hoegler, D.
    Morris, J.
    Parsons, C.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S6 - S7
  • [34] Epigenetic Modulation and Therapy of Lymphoid Malignancies.
    Bates, Susan E.
    BLOOD, 2010, 116 (21) : 1762 - 1762
  • [35] FLUDARABINE PHOSPHATE THERAPY IN OTHER LYMPHOID MALIGNANCIES
    KANTARJIAN, HM
    REDMAN, JR
    KEATING, MJ
    SEMINARS IN ONCOLOGY, 1990, 17 (05) : 66 - 70
  • [36] DIAGNOSIS OF LYMPHOID MALIGNANCIES BY N-ALKALINE PHOSPHATASE
    RALPH, P
    BISHIRJIAN, LS
    BLOOD, 1977, 50 (05) : 206 - 206
  • [37] Molecular Markers for Thyroid Cancer Diagnosis, Prognosis, and Targeted Therapy
    Yip, Linwah
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (01) : 43 - 50
  • [38] Molecular Markers for Breast Cancer Diagnosis, Prognosis and Targeted Therapy
    Lang, Julie E.
    Wecsler, Julie S.
    Press, Michael F.
    Tripathy, Debasish
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (01) : 81 - 90
  • [39] MOLECULAR DIAGNOSIS OF HEMATOLOGICAL MALIGNANCIES
    ADRA, CN
    KHALIL, S
    HANNAN, M
    ANNALS OF SAUDI MEDICINE, 1991, 11 (06) : 721 - 724
  • [40] Bone metastases of prostate cancer: Molecular mechanisms, targeted diagnosis and targeted therapy (Review)
    Guo, Xutang
    Li, Shaojun
    ONCOLOGY REPORTS, 2025, 53 (04)
12345